South African Journal of Oncology

AOSIS

Journal websitePeer review: Double-blind review
Evaluation status available after sign-in

About the journal

South African Journal of Oncology is an open-access journal published by AOSIS in South Africa, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 10,280 ZAR. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
AOSIS
ISSN
2518-8704 · 2523-0646
Country
South Africa
Languages
english
Access
Open access
Declared publication charge
10,280 ZAR
Articles in DOAJ
173
Declared review time
14 weeks
Declared peer-review model
double_blind
Official website
https://sajo.org.za

Index listings

  • DOAJ · 2019-02-16
Indexing
DOAJ
APC
10,280 ZAR
Declared review time (DOAJ)
14 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

173

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

14weeks

Works in OpenAlex

169

Last recorded publication year

2025

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

8

i10-index

6

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-12
Added to DOAJ
2019-02-16
Declared plagiarism screening
Declared
Other fees beyond APC
Yes
Declared digital preservation
Portico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
92%
ORCID iDs in current deposits
95%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Alternate titles
SA journal of oncologySAJO
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Advances in Oncology and Radiotherapy
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • Acute Lymphoblastic Leukemia research
  • Advanced Radiotherapy Techniques
  • Acute Lymphoblastic Leukemia research
  • Advanced Radiotherapy Techniques
  • Advanced Radiotherapy Techniques
Show all subjects (75)
  • Childhood Cancer Survivors' Quality of Life
  • Lymphoma Diagnosis and Treatment
  • Global Cancer Incidence and Screening
  • Childhood Cancer Survivors' Quality of Life
  • Acute Lymphoblastic Leukemia research
  • Advances in Oncology and Radiotherapy
  • Advances in Oncology and Radiotherapy
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Breast Cancer Treatment Studies
  • Head and Neck Cancer Studies
  • Viral-associated cancers and disorders
  • Breast Cancer Treatment Studies
  • Sarcoma Diagnosis and Treatment
  • Breast Lesions and Carcinomas
  • Acute Myeloid Leukemia Research
  • Hematological disorders and diagnostics
  • Breast Cancer Treatment Studies
  • Cancer survivorship and care
  • Chronic Lymphocytic Leukemia Research
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • Glioma Diagnosis and Treatment
  • Acute Myeloid Leukemia Research
  • Viral-associated cancers and disorders
  • Acute Myeloid Leukemia Research
  • Glioma Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Testicular diseases and treatments
  • Prostate Cancer Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Sarcoma Diagnosis and Treatment
  • Cancer survivorship and care
  • Esophageal Cancer Research and Treatment
  • Educational Robotics and Engineering
  • Human auditory perception and evaluation
  • Head and Neck Cancer Studies
  • Cancer Treatment and Pharmacology
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
  • Prostate Cancer Diagnosis and Treatment
  • Endometrial and Cervical Cancer Treatments
  • Palliative Care and End-of-Life Issues
  • Cervical Cancer and HPV Research
  • Neutropenia and Cancer Infections
  • Radiation Therapy and Dosimetry
  • Chronic Lymphocytic Leukemia Research
  • Economic and Financial Impacts of Cancer
  • Retinoids in leukemia and cellular processes
  • Palliative Care and End-of-Life Issues
  • Cervical Cancer and HPV Research
  • Economic and Financial Impacts of Cancer
  • Neutropenia and Cancer Infections
  • Management of metastatic bone disease
  • Palliative and Oncologic Care
  • Cancer survivorship and care
  • Neutropenia and Cancer Infections
  • Management of metastatic bone disease
  • Esophageal Cancer Research and Treatment
  • Prostate Cancer Treatment and Research
  • Renal cell carcinoma treatment
  • Head and Neck Surgical Oncology
  • Glioma Diagnosis and Treatment
  • Prostate Cancer Treatment and Research

Keywords (DOAJ)

  • oncology
  • cancer care

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: